Skip to content
Search
SEARCH FOR AN ARTICLE
Home
investing in biotech
investing in biotech
![All You Need to Know About BioNTech SE Sponsored ADR (BNTX) Rating Upgrade to Buy]()
December 13, 2022
![bluebird (BLUE) Up on Positive Data on Gene Therapies at ASH]()
December 13, 2022
![Vertex (VRTX) to Start Clinical Study on mRNA-based CF Therapy]()
December 13, 2022
![Fate Therapeutics Features Multiple Novel Approaches to Eliminate Conditioning Chemotherapy for Off-the-shelf, iPSC-derived Cell Therapies at 2022 ASH Annual Meeting]()
December 13, 2022
![argenx Appoints Ana Cespedes to Board of Directors]()
December 12, 2022
![Pfizer (PFE), BNTX’s COVID-Flu Combo Jab Gets FDA Fast Track Tag]()
December 12, 2022
![CRISPR Therapeutics Provides Update on Its Ongoing Phase 1 CARBON(TM) Trial of CTX110®]()
December 12, 2022
![3 Medical Stocks With Solid Growth Drivers to Keep Track Of]()
December 12, 2022
![GT Biopharma and Fate Therapeutics Present Preclinical Data Highlighting Novel Dual Antigen Targeting Approach For The Treatment of AML at ASH 2022]()
December 12, 2022
![Agios Presents Updated PYRUKYND® (mitapivat) Long-term Extension Data Demonstrating Sustained Clinical Benefits in Adults with Pyruvate Kinase (PK) Deficiency at 64th ASH Annual Meeting and Exposition]()
December 11, 2022
